(-)-Epicatechin Improves Vasoreactivity and Mitochondrial Respiration in Thermoneutral-Housed Wistar Rat Vasculature

Overview

Journal Nutrients

Date 2022 Mar 10

PMID 35268072

Authors

Ji Hye Chun

Melissa M Henckel

Leslie A Knaub

Sara E Hull

Greg B Pott

Lori A Walker

Jane E-B Reusch

Amy C Keller

Affiliations

Soon will be listed here.

Abstract

Cardiovascular disease (CVD) is a global health concern. Vascular dysfunction is an aspect of CVD, and novel treatments targeting vascular physiology are necessary. In the endothelium, eNOS regulates vasodilation and mitochondrial function; both are disrupted in CVD. (−)-Epicatechin, a botanical compound known for its vasodilatory, eNOS, and mitochondrial-stimulating properties, is a potential therapy in those with CVD. We hypothesized that (−)-epicatechin would support eNOS activity and mitochondrial respiration, leading to improved vasoreactivity in a thermoneutral-derived rat model of vascular dysfunction. We housed Wistar rats at room temperature or in thermoneutral conditions for a total of 16 week and treated them with 1mg/kg body weight (−)-epicatechin for 15 day. Vasoreactivity, eNOS activity, and mitochondrial respiration were measured, in addition to the protein expression of upstream cellular signaling molecules including AMPK and CaMKII. We observed a significant improvement of vasodilation in those housed in thermoneutrality and treated with (−)-epicatechin (p < 0.05), as well as dampened mitochondrial respiration (p < 0.05). AMPK and CaMKIIα and β expression were lessened with (−)-epicatechin treatment in those housed at thermoneutrality (p < 0.05). The opposite was observed with animals housed at room temperature supplemented with (−)-epicatechin. These data illustrate a context-dependent vascular response to (−)-epicatechin, a candidate for CVD therapeutic development.

Citing Articles

Cocoa flavanols, Nrf2 activation, and oxidative stress in peripheral artery disease: mechanistic findings in muscle based on outcomes from a randomized trial.

Ismaeel A, McDermott M, Joshi J, Sturgis J, Zhang D, Ho K Am J Physiol Cell Physiol. 2024; 326(2):C589-C605.

PMID: 38189132 PMC: 11193455. DOI: 10.1152/ajpcell.00573.2023.

(-)-Epicatechin Inhibits Metastatic-Associated Proliferation, Migration, and Invasion of Murine Breast Cancer Cells In Vitro.

Perez-Duran J, Luna A, Portilla A, Martinez P, Ceballos G, Ortiz-Flores M Molecules. 2023; 28(17).

PMID: 37687058 PMC: 10488497. DOI: 10.3390/molecules28176229.

The Content of Phenolic Compounds and Mineral Elements in Edible Nuts.

Wozniak M, Waskiewicz A, Ratajczak I Molecules. 2022; 27(14).

PMID: 35889199 PMC: 9316459. DOI: 10.3390/molecules27144326.

References

Kingma B, Frijns A, Schellen L, van Marken Lichtenbelt W . Beyond the classic thermoneutral zone: Including thermal comfort. Temperature (Austin). 2016; 1(2):142-9. PMC: 4977175. DOI: 10.4161/temp.29702. View

Yamazaki K, Andreyev A, Ortiz-Vilchis P, Petrosyan S, Divakaruni A, Wiley S . Intravenous (-)-epicatechin reduces myocardial ischemic injury by protecting mitochondrial function. Int J Cardiol. 2014; 175(2):297-306. PMC: 4506135. DOI: 10.1016/j.ijcard.2014.05.009. View

Kizhakekuttu T, Wang J, Dharmashankar K, Ying R, Gutterman D, Vita J . Adverse alterations in mitochondrial function contribute to type 2 diabetes mellitus-related endothelial dysfunction in humans. Arterioscler Thromb Vasc Biol. 2012; 32(10):2531-9. PMC: 3570053. DOI: 10.1161/ATVBAHA.112.256024. View

Li C, Reif M, Craige S, Kant S, Keaney Jr J . Endothelial AMPK activation induces mitochondrial biogenesis and stress adaptation via eNOS-dependent mTORC1 signaling. Nitric Oxide. 2016; 55-56:45-53. PMC: 4860108. DOI: 10.1016/j.niox.2016.03.003. View

Garate-Carrillo A, Navarrete-Yanez V, Ortiz-Vilchis P, Guevara G, Castillo C, Mendoza-Lorenzo P . Arginase inhibition by (-)-Epicatechin reverses endothelial cell aging. Eur J Pharmacol. 2020; 885:173442. PMC: 7418791. DOI: 10.1016/j.ejphar.2020.173442. View

Ramirez-Sanchez I, De Los Santos S, Gonzalez-Basurto S, Canto P, Mendoza-Lorenzo P, Palma-Flores C . (-)-Epicatechin improves mitochondrial-related protein levels and ameliorates oxidative stress in dystrophic δ-sarcoglycan null mouse striated muscle. FEBS J. 2014; 281(24):5567-80. PMC: 4262719. DOI: 10.1111/febs.13098. View

Keller A, Knaub L, McClatchey P, Connon C, Bouchard R, Miller M . Differential Mitochondrial Adaptation in Primary Vascular Smooth Muscle Cells from a Diabetic Rat Model. Oxid Med Cell Longev. 2016; 2016:8524267. PMC: 4737048. DOI: 10.1155/2016/8524267. View

Miller M, Knaub L, Olivera-Fragoso L, Keller A, Balasubramaniam V, Watson P . Nitric oxide regulates vascular adaptive mitochondrial dynamics. Am J Physiol Heart Circ Physiol. 2013; 304(12):H1624-33. PMC: 3680775. DOI: 10.1152/ajpheart.00987.2012. View

Gibbons G, Dzau V . The emerging concept of vascular remodeling. N Engl J Med. 1994; 330(20):1431-8. DOI: 10.1056/NEJM199405193302008. View

10.

Laurent S, Alivon M, Beaussier H, Boutouyrie P . Aortic stiffness as a tissue biomarker for predicting future cardiovascular events in asymptomatic hypertensive subjects. Ann Med. 2012; 44 Suppl 1:S93-7. DOI: 10.3109/07853890.2011.653398. View

11.

Overton J . Phenotyping small animals as models for the human metabolic syndrome: thermoneutrality matters. Int J Obes (Lond). 2010; 34 Suppl 2:S53-8. DOI: 10.1038/ijo.2010.240. View

12.

Nisoli E, Tonello C, Cardile A, Cozzi V, Bracale R, Tedesco L . Calorie restriction promotes mitochondrial biogenesis by inducing the expression of eNOS. Science. 2005; 310(5746):314-7. DOI: 10.1126/science.1117728. View

13.

Babu G, Pyne G, Zhou Y, Okwuchukuasanya C, Brayden J, Osol G . Isoform switching from SM-B to SM-A myosin results in decreased contractility and altered expression of thin filament regulatory proteins. Am J Physiol Cell Physiol. 2004; 287(3):C723-9. DOI: 10.1152/ajpcell.00029.2004. View

14.

Ramirez-Sanchez I, Maya L, Ceballos G, Villarreal F . (-)-epicatechin activation of endothelial cell endothelial nitric oxide synthase, nitric oxide, and related signaling pathways. Hypertension. 2010; 55(6):1398-405. PMC: 2874202. DOI: 10.1161/HYPERTENSIONAHA.109.147892. View

15.

Lee I . Regulation of Cytochrome Oxidase by Natural Compounds Resveratrol, (-)-Epicatechin, and Betaine. Cells. 2021; 10(6). PMC: 8229178. DOI: 10.3390/cells10061346. View

16.

DAVISON K, Coates A, Buckley J, Howe P . Effect of cocoa flavanols and exercise on cardiometabolic risk factors in overweight and obese subjects. Int J Obes (Lond). 2008; 32(8):1289-96. DOI: 10.1038/ijo.2008.66. View

17.

Zieman S, Melenovsky V, Kass D . Mechanisms, pathophysiology, and therapy of arterial stiffness. Arterioscler Thromb Vasc Biol. 2005; 25(5):932-43. DOI: 10.1161/01.ATV.0000160548.78317.29. View

18.

Taub P, Ramirez-Sanchez I, Ciaraldi T, Perkins G, Murphy A, Naviaux R . Alterations in skeletal muscle indicators of mitochondrial structure and biogenesis in patients with type 2 diabetes and heart failure: effects of epicatechin rich cocoa. Clin Transl Sci. 2012; 5(1):43-7. PMC: 5439909. DOI: 10.1111/j.1752-8062.2011.00357.x. View

19.

Maloney S, Fuller A, Mitchell D, Gordon C, Overton J . Translating animal model research: does it matter that our rodents are cold?. Physiology (Bethesda). 2014; 29(6):413-20. DOI: 10.1152/physiol.00029.2014. View

20.

Gutierrez-Salmean G, Ortiz-Vilchis P, Vacaseydel C, Garduno-Siciliano L, Chamorro-Cevallos G, Meaney E . Effects of (-)-epicatechin on a diet-induced rat model of cardiometabolic risk factors. Eur J Pharmacol. 2014; 728:24-30. DOI: 10.1016/j.ejphar.2014.01.053. View